Brief: Sangamo Therapeutics Q2 EPS USD -0.66
08/08/2023 21:01
Aug 08 (Reuters) - Sangamo Therapeutics Q2 adjusted operating expenses USD 72.3 million. * Q2 operating expenses USD 130.4 million * Q2 operating income USD -123.572 million * Q2 net income USD -114.506 million * Q2 revenue USD 6.835 million vs. IBES estimate USD 14.8 million